Innovent Biologics Inc. (IVBXF) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Innovent Biologics Inc.

    OTC: IVBXF · Real-Time Price · USD
    12.72
    0.34 (2.75%)
    At close: Oct 03, 2025, 1:56 PM
    12.50
    -1.73%
    After-hours: Oct 02, 2025, 12:07 PM EDT

    Innovent Biologics Balance Sheet Statement

    Financials in CNY. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 7.51B 10.05B 1.02B 1.36B
    Short-Term Investments
    		 375.56M 867.53M 7.25B 6.58B
    Long-Term Investments
    		 3.9B 794.09M 630.2M -6.16B
    Other Long-Term Assets
    		 499.02M 1.72B 193.06M 6.71B
    Receivables
    		 1.57B 1.01B 911.79M 1.18B
    Inventory
    		 822.17M 968.09M 1.43B 1.35B
    Other Current Assets
    		 n/a 484.38M n/a 6.63M
    Total Current Assets
    		 10.27B 13.43B 11.51B 11.55B
    Property-Plant & Equipment
    		 5.65B 4.66B 4.06B 3.38B
    Goodwill & Intangibles
    		 1.28B 27.79M 1.2B 772.19M
    Total Long-Term Assets
    		 11.33B 7.2B 6.08B 4.69B
    Total Assets
    		 21.6B 20.63B 17.59B 16.24B
    Account Payables
    		 357.68M 372.55M 325.62M 195.05M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 405.1M 1.2B 888M 365M
    Other Current Liabilities
    		 2.32B 728.33M 741.92M 790.15M
    Total Current Liabilities
    		 4.37B 4.48B 3.5B 3.05B
    Long-Term Debt
    		 2.41B 2.33B 2.22B 2.02B
    Other Long-Term Liabilities
    		 1.7B 262.71M 162.31M 342K
    Total Long-Term Liabilities
    		 4.12B 3.62B 3.36B 2.86B
    Total Liabilities
    		 8.48B 8.1B 6.86B 5.91B
    Total Debt
    		 2.83B 3.62B 3.23B 2.5B
    Book Value
    		 13.12B 12.53B 10.73B 10.33B
    Book Value Per Share
    		 8.32 8.03 7.20 7.12
    Common Stock
    		 113K 112K 105K 101K
    Retained Earnings
    		 -15.91B -15.77B -14.74B -12.56B
    Comprehensive Income
    		 1.3B 970.54M 763.86M 397.02M
    Shareholders Equity
    		 13.12B 12.53B 10.73B 10.33B
    Total Investments
    		 4.28B 1.66B 630.2M 417.25M

    Add to Watchlist